KMTS (Kestra Medical Technologies) Asset Turnover: 0.08 (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KMTS Kestra Medical Technologies Ltd KMTS
10 GF Score
Price $24.24
! 4 Warning Signs
View Full Analysis

What is Kestra Medical Technologies Asset Turnover?

Kestra Medical Technologies KMTS -2.34% 10 Asset Turnover is 0.08 as of Jan. 2026. GuruFocus rates KMTS with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Kestra Medical Technologies's Revenue for the three months ended in Jan. 2026 was $24.55 Mil. Kestra Medical Technologies's Total Assets for the quarter that ended in Jan. 2026 was $313.02 Mil. Therefore, Kestra Medical Technologies's Asset Turnover for the quarter that ended in Jan. 2026 was 0.08.

Asset Turnover is linked to ROE % through Du Pont Formula. Kestra Medical Technologies's annualized ROE % for the quarter that ended in Jan. 2026 was -60.46%. It is also linked to ROA % through Du Pont Formula. Kestra Medical Technologies's annualized ROA % for the quarter that ended in Jan. 2026 was -43.66%.


Kestra Medical Technologies  (NAS:KMTS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Kestra Medical Technologies's annulized ROE % for the quarter that ended in Jan. 2026 is

ROE %**(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-136.664/226.035
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-136.664 / 98.208)*(98.208 / 313.0215)*(313.0215/ 226.035)
=Net Margin %*Asset Turnover*Equity Multiplier
=-139.16 %*0.3137*1.3848
=ROA %*Equity Multiplier
=-43.66 %*1.3848
=-60.46 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Kestra Medical Technologies's annulized ROA % for the quarter that ended in Jan. 2026 is

ROA %(Q: Jan. 2026 )
=Net Income/Total Assets
=-136.664/313.0215
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-136.664 / 98.208)*(98.208 / 313.0215)
=Net Margin %*Asset Turnover
=-139.16 %*0.3137
=-43.66 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Kestra Medical Technologies Asset Turnover Related Terms


Kestra Medical Technologies Asset Turnover Historical Data

* Premium members only.

The historical data trend for Kestra Medical Technologies's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kestra Medical Technologies Asset Turnover Chart

Kestra Medical Technologies Annual Data
Trend Apr20 Apr21 Apr23 Apr24
Asset Turnover
0.00 0.00 0.22 0.66

Kestra Medical Technologies Quarterly Data
Apr20 Jul20 Apr21 Jul21 Apr23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.09 0.07 0.09 0.08

KMTS vs ATRC, STAA, BLFS: Asset Turnover Comparison

For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kestra Medical Technologies Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Kestra Medical Technologies's Asset Turnover falls into.


KMTS
10GF Score
Kestra Medical Technologies Ltd KMTS
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kestra Medical Technologies Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Kestra Medical Technologies's Asset Turnover for the fiscal year that ended in Apr. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Apr. 2024 )/( (Total Assets (A: Apr. 2023 )+Total Assets (A: Apr. 2024 ))/ count )
=27.814/( (38.656+45.949)/ 2 )
=27.814/42.3025
=0.66

Kestra Medical Technologies's Asset Turnover for the quarter that ended in Jan. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jan. 2026 )/( (Total Assets (Q: Oct. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=24.552/( (246.701+379.342)/ 2 )
=24.552/313.0215
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.08 mean?
Kestra Medical Technologies (KMTS) has a Asset Turnover of 0.08 as of Jan. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Kestra Medical Technologies and its competitors.
Is Kestra Medical Technologies' Asset Turnover too high?
Kestra Medical Technologies' current Asset Turnover is 0.08. Overall, Kestra Medical Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Asset Turnover compare to ATRC and STAA?
Kestra Medical Technologies' Asset Turnover of 0.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Kestra Medical Technologies and its competitors. Kestra Medical Technologies's current Asset Turnover is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Asset Turnover of 0.08. The current Asset Turnover is 0.08. Kestra Medical Technologies' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Asset Turnover is 0.08 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kestra Medical Technologies Business Description

Address 3933 Lake Washington Boulevard NE, Suite 200, Kirkland, WA, USA, 98033
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
10GF Score

Get the complete analysis for KMTS

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.24
Price